According to statistics from the World Health Organization (WHO), more than 109 million people are infected with the SARS-CoV-2 virus and 2.4 million people die from the respiratory distress it causes – known as COVID-19.
Fortunately, we have eight vaccines that are being distributed to many countries around the world to combat a pandemic. Along with that, more than 300 other COVID-19 vaccines are being studied and 66 of these are heading to clinical trials.
For a full picture, a map of COVID-19 vaccine around the world, let’s take a look at the 5 statistical charts below:
This statistics table presents six major technological platforms that help scientists develop vaccines against the corona virus SARS-CoV-2, which is causing the COVID-19 pandemic. Most of these vaccine platforms focus on the viral prickly proteins, which help them penetrate the cells lining the respiratory tract and lung cells.
Using any vaccine platform, from nucleic acid technology (RNA and DNA), virus vectors not replicated (Viral vector), peptide, recombinant protein (virus-like partical, protein sub-unit), While the live virus is attenuated and the inactivated virus, the ultimate goal of the injections is still to teach the human immune system to recognize the SARS-CoV-2 virus and destroy it.
Vietnam currently has 3 COVID-19 vaccines based on the virus vector technology that does not copy, which is researched by IVAC, VABIOTECH and NANOGEN. In particular, NANOGEN’s Nano Covax vaccine has completed phase I clinical trials and is preparing to proceed to phase II and III clinical trials.
Vaccines “made in Vietnam“This has brought us into a group of 40 countries around the world that have developed and tested the COVID-19 vaccine themselves.
Eight different COVID-19 vaccines are currently in use worldwide and 172 million people have been vaccinated. That means that for every 100 people, an average of 2.2 people worldwide received the first shot of COVID-19.
Pfizer and BioNTech mRNA-based vaccines are being used in 61 countries around the world including the United States, Canada, Mexico, the European Union and Saudi Arabia. Based on mRNA technology this means that the vaccine needs to be stored in a freezer at -70 degrees Celsius.
That leaves many low-income countries without cold storage systems unable to access this vaccine. They will usually use the AstraZeneca vaccine, with normal storage conditions between 2 and 8 degrees Celsius. The AstraZeneca vaccine in partnership with Oxford University is being distributed to 41 countries.
Although the World Health Organization has said that the vaccine is safe for all adults, some countries including Germany and Poland are restricting AstraZeneca’s vaccine, which is only given to those under 65 years old.
In some countries with close ties to China, the Sinopharm and Sinovac vaccines developed by China have been used. The same goes for the Russian Sputnik V vaccine, which is currently used by several former Eastern European bloc countries including Hungary.
This statistic was made by the Duke Center for Global Health Development (DGHIC) based on published data from countries, which stated the COVID-19 vaccine they had ordered. America is the leading country, with 2.6 billion doses, because it owns the most domestic vaccines.
Next is the group of European Union (EU) countries with orders up to 2 billion doses. India, a country of more than 1 billion people, also has a domestic vaccine factory and has 1.6 billion doses of COVID-19 on hand.
According to DGHIC, Vietnam is currently negotiating with many partners to obtain 150 million doses of COVID-19 vaccine. The latest information from the Ministry of Health said that Vietnam could receive 30 million doses of AstraZeneca’s vaccine in advance this year.
In addition, the COVAX-19 global vaccine distribution initiative COVAX has also committed to support Vietnam with approximately 4.8 to 8.2 million doses of COVID-19 vaccine for free.
Due to rapid order and approval progress, along with good infrastructure for vaccine distribution and management, several countries are leading the way in the COVID-19 vaccination race.
Webpage “Our World in Data “ Israel has continuously monitored the statistics and found that Israel is the leading country in the proportion of COVID-19 vaccinations per population. They have crossed the threshold of 60-70% of the immunized population to essentially achieve community immunity.
As of February 15, Israel administered COVID-19 vaccine to about 6.3 million people, or 72.58% of the population. That was the highest rate of vaccination COVID-19 to date, significantly higher than 50.61% in the UAE and 22.23% in the UK.
A report by the Economist Intelligence Unit shows that there is a long way from now to achieving public immunity worldwide through the vaccination of COVID-19.
Although the United States, Israel, the Gulf states and European countries have a target of vaccinating 60-70% of the adult population by the second half of 2021, the majority of the rest of the world gender will take longer.
The Americas and Latin America as a whole could complete the immunization target by mid-2022. But in Asia, the predictions look bleak. Even wealthy economies like Japan and South Korea take more than a year from now to vaccinate 60-70% of the adult population.
Vietnam is also expected to hit its target around this time, ie mid-2022. While Taiwan is expected to complete its vaccination target earlier in the second half of 2021.
For the majority of the world’s non-industrial nations, comprising almost all of Africa, their immunization schedule is required until 2023.